CSF hypocretin levels in Guillain–Barré syndrome and other inflammatory neuropathies

CSF hypocretin-1 was measured in 28 Guillain–Barre syndrome (GBS), 12 Miller–Fisher syndrome, 12 chronic inflammatory demyelinating polyneuropathy (CIDP), and 48 control subjects. Seven GBS subjects had undetectably low hypocretin-1 levels (